Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.6% during the fourth quarter, Holdings Channel reports. The firm owned 19,976 shares of the company’s stock after acquiring an additional 1,056 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Acadia Healthcare were worth $1,553,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Strs Ohio increased its position in shares of Acadia Healthcare by 10.9% during the fourth quarter. Strs Ohio now owns 82,288 shares of the company’s stock worth $6,398,000 after purchasing an additional 8,100 shares in the last quarter. Vontobel Holding Ltd. increased its position in Acadia Healthcare by 6.5% in the 4th quarter. Vontobel Holding Ltd. now owns 74,658 shares of the company’s stock valued at $5,805,000 after acquiring an additional 4,538 shares during the period. Phocas Financial Corp. acquired a new position in Acadia Healthcare in the 4th quarter valued at about $6,887,000. Louisiana State Employees Retirement System acquired a new position in Acadia Healthcare in the 4th quarter valued at about $2,014,000. Finally, Cerity Partners LLC acquired a new position in Acadia Healthcare in the 4th quarter valued at about $276,000.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.80% of the company’s stock.

Acadia Healthcare Price Performance

Shares of ACHC opened at $73.38 on Friday. Acadia Healthcare Company, Inc. has a twelve month low of $66.49 and a twelve month high of $87.77. The stock’s 50 day moving average is $78.45 and its two-hundred day moving average is $77.67. The firm has a market capitalization of $6.78 billion, a PE ratio of -293.51, a P/E/G ratio of 2.09 and a beta of 1.31. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.70 EPS. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on ACHC. UBS Group boosted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. TheStreet upgraded Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price objective on the stock in a report on Friday, January 5th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.